Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Gross Margin (2024 - 2025)

Historic Gross Margin for Autolus Therapeutics (AUTL) over the last 2 years, with Q3 2025 value amounting to 35.15%.

  • Autolus Therapeutics' Gross Margin changed N/A to 35.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.21%, marking a year-over-year change of. This contributed to the annual value of 12.52% for FY2024, which is 1125200.0% down from last year.
  • Autolus Therapeutics' Gross Margin amounted to 35.15% in Q3 2025.
  • Autolus Therapeutics' Gross Margin's 5-year high stood at 100.0% during Q1 2024, with a 5-year trough of 39165.52% in Q4 2024.